₹62.34
▼ -2.06 -3.20%
16 Jun 2026
BSE Listed · FMCG
GKB Ophthalmics Ltd. (533212)
Volume: 972Avg Vol 1W: 2,134Avg Vol 1M: 1,79052W Range:₹47.26₹84.9
Key Ratios
Updated just nowMarket Cap—
Current Price₹62.34
Previous Close₹64.4
High / Low (52w)₹84.9 / ₹47.26
Volume972
Avg Vol (1W)2,134
Avg Vol (1M)1,790
Stock P/E0
Book Value₹104.82
Dividend Yield—
ROE-12.66%
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹0.38
P/B0.59
Debt / Equity0.23
50 DMA₹65.48
200 DMA₹62.22
Day change-3.20%
Price Chart
₹62.34▼ 15.33% · 1Y
2025-06-172026-06-16
20-day avg volume: 2K shares
Pros
- Company is almost debt-free.
- Revenue grew 23% YoY.
- Stock trades below its book value.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹30 Cr | ₹57 Cr | ₹30 Cr | ₹32 Cr | ₹31 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹22 Cr | ₹24 Cr | ₹20 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr | ₹20 Cr | ₹19 Cr | ₹15 Cr | ₹17 Cr | ₹17 Cr | ₹15 Cr | ₹7 Cr | ₹16 Cr |
| EBITDA | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹0 Cr | ₹-3 Cr | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹-2 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹-2 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹-1 Cr | ₹-4 Cr | ₹-2 Cr | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹-2 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr | ₹0 Cr |
| EPS | 0.38 | 0.08 | 3.17 | -2.02 | -7.03 | -4.03 | -2.41 | -0.5 | -1.81 | -2.48 | -2.32 | 1.04 | -3.8 | -2.05 | 1.68 | 3.84 | 1.29 | 1.63 | -0.67 | 0.27 | 2.23 | 0.16 | -0.5 | -3.68 | -0.66 |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹110 Cr | ₹90 Cr | ₹76 Cr | ₹72 Cr | ₹59 Cr | ₹59 Cr |
| EBITDA | ₹-5 Cr | ₹-1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹-1 Cr |
| Net Profit | ₹-7 Cr | ₹-3 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹-2 Cr |
| EPS | -13.98 | -5.58 | -0.33 | 2.53 | -1.8 | -3.65 |
Balance Sheet
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Total Assets | ₹125 Cr | ₹115 Cr | ₹112 Cr | ₹110 Cr | ₹107 Cr | ₹102 Cr |
| Total Liabilities | ₹69 Cr | ₹50 Cr | ₹45 Cr | ₹43 Cr | ₹41 Cr | ₹43 Cr |
| Equity | ₹56 Cr | ₹64 Cr | ₹67 Cr | ₹67 Cr | ₹66 Cr | ₹59 Cr |
| Total Debt | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr |
Cash Flow
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Operating | ₹-3 Cr | ₹4 Cr | ₹-3 Cr | ₹5 Cr | ₹7 Cr | ₹3 Cr |
| Investing | ₹3 Cr | ₹-2 Cr | ₹1 Cr | ₹-4 Cr | ₹-17 Cr | ₹-4 Cr |
| Financing | ₹1 Cr | ₹-2 Cr | ₹-2 Cr | ₹-2 Cr | ₹3 Cr | ₹4 Cr |
| Free Cash Flow | ₹-3 Cr | ₹4 Cr | ₹-3 Cr | ₹5 Cr | ₹7 Cr | ₹3 Cr |
Shareholding
Promoter 51.13% Institutions 1.79% Public 47.09%
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search